SHGA
NWBOW

Sand Hill Global Advisors’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

Sand Hill Global Advisors’s Portfolio NWBOW Stock Details NWBOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,500
Closed -$35K – 79
2013
Q4 		$35K Buy
+12,500
New +$33.4K 0.01% 76

Other funds holding NWBOW

Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Sand Hill Global Advisors's NWBOW Position: Q1 2014 in Review

Sand Hill Global Advisors sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q1 2014, closing a stake of 12,500 shares — an estimated $35K sold.

Sand Hill Global Advisors first reported a position in NWBOW in Q4 2013 and held it in 1 quarter. The position peaked at $35K in Q4 2013. 4 funds tracked by Wall St. Rank hold NWBOW as of Q1 2014.

  • Sand Hill Global Advisors reported no remaining Northwest Biotherapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
  • Sand Hill Global Advisors sold 12,500 Northwest Biotherapeutics, Inc. shares in Q1 2014, an estimated $35K.
  • Sand Hill Global Advisors first reported a position in Northwest Biotherapeutics, Inc. in Q4 2013 and held it in 1 quarter.
  • Sand Hill Global Advisors's Northwest Biotherapeutics, Inc. position peaked at $35K in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q1 2014.

Based on Sand Hill Global Advisors's 13F filing for Q1 2014, filed 12 May 2014.